MarketPulse — Real-Time Financial News & Market Analysis

Latest News

8,915 articles
Mon, Mar 23
BenzingaBenzinga··Globe Newswire

Powell Max Pivots to Solar: $9M Bid for Boston Solar Signals Strategic Shift

Powell Max signs LOI to acquire Boston Solar for $9M plus $7M debt assumption, marking major strategic pivot from financial communications into renewable energy sector.
PMAXacquisitionrenewable energy
The Motley FoolThe Motley Fool··Alex Carchidi

SEC Classifies 16 Cryptocurrencies as Digital Commodities, Unlocking Growth Potential

SEC and CFTC classify 16 cryptocurrencies as digital commodities, removing regulatory uncertainty for Ethereum, Solana, and XRP, unlocking significant valuation potential.
XRPCETHVSOLZregulatory claritystaking
The Motley FoolThe Motley Fool··Matthew Benjamin

Three Sectors Defy Market Sell-Off as Geopolitical Tensions Reshape Investor Flows

Energy, AI hardware, and cybersecurity stocks surge as S&P 500 falls 4.5% on Middle East tensions, revealing selective crisis-driven investor rotation.
DELLSNDKMUORCLORCLpD+11AI infrastructuremarket sell-off
BenzingaBenzinga··Piero Cingari

Trump's Iran Pause Sparks Oil Rout: WTI Crashes to $90 as Energy Bets Unwind

President Trump announced a 5-day pause on Iran strikes, sending crude prices plummeting 8%. Oil markets tumble while travel stocks surge.
SPYDALCCLUALLUV+2oil pricescruise lines
The Motley FoolThe Motley Fool··Selena Maranjian

High Yields Beckon: Can Campbell's, Healthpeak, and Kraft Heinz Deliver for Income Investors?

Three S&P 500 stocks offer 6.9%-7.4% yields amid significant declines. Campbell's, Kraft Heinz, and Healthpeak Properties may offer value, but thorough due diligence is essential.
KHCCPBDOCstock valuationS&P 500
GlobeNewswire Inc.GlobeNewswire Inc.··Signify

Signify Continues Share Buyback Program, Repurchases 70,000 Shares for €1.3M

Signify repurchased 70,000 shares for €1.3M in March, bringing total repurchases to 523,393 shares for €10.1M under its February 2026 program.
PHPPYcapital allocationshareholder returns
BenzingaBenzinga··Globe Newswire

Reviva Pharmaceuticals Closes $10M Offering to Fund Schizophrenia Drug Trial

Reviva Pharmaceuticals closed a $10M public offering at $1.50/share to fund its RECOVER-2 Phase 3 schizophrenia trial, maintaining $23M cash through Q1 2027.
RVPHwarrantspublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Fusion Inc. Appoints Veteran CFO, Completes Audits Ahead of SEC Registration

$AMFN appoints 30-year finance veteran Michael Carlson as CFO, completes independent audits, and files Form 10 with SEC.
AMFNfusion energyTexatron™ platform
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Giftify Deploys Second AI Agent at CardCash, Targeting Margin Expansion Through Automation

Giftify's CardCash deploys 85%-accurate AI order review system as part of ambitious five-agent roadmap to reduce costs and improve margins.
GIFTlabor automationcost reduction
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Byrna Technologies to Report Q1 2026 Results; Earnings Call Scheduled for April 9

Byrna Technologies will report fiscal Q1 2026 financial results on April 9, 2026 at 9:00 a.m. ET via conference call with management Q&A.
BYRNfinancial resultsconference call
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Expensify Faces $9.5M IPO Settlement Over Registration Statement Violations

Federal court approves $9.5M class action settlement for Expensify IPO purchasers over alleged registration statement inaccuracies, with fairness hearing scheduled June 2026.
EXFYsecurities fraudIPO
GlobeNewswire Inc.GlobeNewswire Inc.··Amphista Therapeutics

Amphista Therapeutics Showcases Next-Gen Cancer Degraders at AACR Meeting

Amphista Therapeutics presents three programs at AACR 2026, including oral presentation on AMX-883 BRD9 degrader for AML treatment.
LLYNVScancer treatmentprotein degradation
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

$BIOXCEL Settlement: $9.75M Class Action Approved for Securities Fraud Claims

BioXcel Therapeutics settles $9.75M class action over securities purchased March-June 2023. Fairness hearing scheduled September 2026.
BTAIinvestor compensationsecurities litigation
Investing.comInvesting.com··Brian Gilmartin

S&P 500 Earnings Resilience: Forward EPS Hits $319.98 Despite Market Decline

S&P 500 forward EPS estimates hit $319.98 despite 5% YTD decline, driven by strong tech and semiconductor earnings, suggesting potential market oversold conditions.
MUORCLORCLpDmarket correctiontechnology sector
BenzingaBenzinga··Stjepan Kalinic

Gold, Silver Crushed by War Fallout as Contrarians Spot Value Play

Gold and silver plunge 25.5% and 50% from peaks amid war-driven volatility, but contrarians see positioning-driven selloff creating opportunities in precious metals producers.
AEMNEMBHPRIOBmarket volatilityvalue investing
The Motley FoolThe Motley Fool··Matt Frankel, Cfp

Shopify Stock Tumbles on AI Fears: Why Contrarian Investors See a Buying Opportunity

Shopify stock declines on AI disruption fears in 2026, but contrarian investors view the selloff as a buying opportunity given the company's platform stickiness and integration potential.
SHOPstock declineAI disruption
BenzingaBenzinga··Soligenix, Inc.

Soligenix's HyBryte Shows Promise Against Cutaneous Lymphoma at 2026 Workshop

Soligenix's HyBryte™ cutaneous lymphoma therapy shows positive results ahead of 2026 presentation, with FDA awarding $2.6M development grant.
SNGXPhase 3 clinical trialFDA approval
BenzingaBenzinga··Djs Law Group

Lufax Faces Class Action Lawsuit Over Securities Violations and Internal Controls

Lufax Holding Ltd ($LU) sued for securities law violations, accused of false statements and inadequate internal controls. Shareholders urged to contact legal representatives.
LUsecurities fraudclass action lawsuit
BenzingaBenzinga··Globe Newswire

SL Green Boosts Dividend to $2.47/Share Amid Manhattan Office Recovery

SL Green boosts annual dividend to $2.47/share, yielding 6.6%, supported by record Manhattan office leasing and 95% occupancy recovery target.
SLGSLGpIdividend announcementoccupancy rates
The Motley FoolThe Motley Fool··Neil Patel

Three Essential Questions Every Stock Investor Must Answer Before Committing Capital

Successful stock investors must assess how companies generate revenue, identify sustainable competitive advantages, and evaluate fair valuation before buying.
AMZNBRK.ABRK.Bvaluationstock analysis